The Incidence, Clinical Characteristics and Outcome of Infective Endocarditis Among Intravenous Drug Abusers Versus Non-Drug Abusers.

Launched by ASSIUT UNIVERSITY · Jan 4, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a serious heart infection called infective endocarditis (IE) in people who use intravenous drugs compared to those who do not. The researchers want to understand how common this infection is among both groups, what symptoms and complications they experience, and how well they respond to medical treatments or surgery. The goal is to gather important information that could help improve care for these patients in the future.

To participate in the trial, individuals must be adults over 18 years old and have either a confirmed or suspected case of infective endocarditis. However, those who have been cleared of the diagnosis after thorough testing will not be included. Participants can expect to undergo various assessments related to their health and treatment outcomes. This study is currently recruiting participants, and both men and women are welcome to join. Your involvement could contribute to better understanding and treatment of this condition, particularly in the context of intravenous drug use.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult Patients (\>18 years) with definite or possible IE.
• Exclusion Criteria:
• • Patients with rejected diagnosis of infective endocarditis after workup, according to modified Duke's criteria.